Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 6Neoplasms 4Lymphoma, Follicular 4Lymphoma, Non-Hodgkin 3Neoplasms, Plasma Cell 2Multiple Myeloma 2Melanoma 2Leukemia 2Hematologic Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Neoplasms, Nerve Tissue 1Neoplasms, Germ Cell and Embryonal 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Hodgkin Disease 1Healthy Volunteer 1Glioma 1Glioblastoma 1Genetic Diseases, Inborn 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 116Peripheral Blood Stem Cell Transplantation 96Filgrastim 73Etoposide 68fludarabine phosphate 61Radiotherapy 58Rituximab 57Cyclosporine 49Mycophenolic Acid 46Busulfan 44Melphalan 40Cytarabine 37Whole-Body Irradiation 36Antilymphocyte Serum 35Tacrolimus 34Methotrexate 33Vincristine 27Methylprednisolone 27Carmustine 26Prednisone 24Doxorubicin 23sargramostim 20Cord Blood Stem Cell Transplantation 18Cisplatin 17Granulocyte Colony-Stimulating Factor 15Flow Cytometry 15Ifosfamide 14Carboplatin 14Polymerase Chain Reaction 13Paclitaxel 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Immunoblastic × keyhole-limpet hemocyanin × Clear all
NCT00004197 2023-09-07

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

University of Nebraska

Phase 2 Completed
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡